These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 34756014)

  • 1. Recent Advances in the Noninvasive Delivery of mRNA.
    Qin M; Du G; Sun X
    Acc Chem Res; 2021 Dec; 54(23):4262-4271. PubMed ID: 34756014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in microneedle-based drug delivery: Special emphasis on its use in paediatric population.
    Duarah S; Sharma M; Wen J
    Eur J Pharm Biopharm; 2019 Mar; 136():48-69. PubMed ID: 30633972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microneedle technology for potential SARS-CoV-2 vaccine delivery.
    McNamee M; Wong S; Guy O; Sharma S
    Expert Opin Drug Deliv; 2023 Jun; 20(6):799-814. PubMed ID: 37128730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microneedles as an alternative technology for transdermal drug delivery systems: a patent review.
    Queiroz MLB; Shanmugam S; Santos LNS; Campos CA; Santos AM; Batista MS; Araújo AAS; Serafini MR
    Expert Opin Ther Pat; 2020 Jun; 30(6):433-452. PubMed ID: 32164470
    [No Abstract]   [Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microneedle-based vaccines.
    Prausnitz MR; Mikszta JA; Cormier M; Andrianov AK
    Curr Top Microbiol Immunol; 2009; 333():369-93. PubMed ID: 19768415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging skin-targeted drug delivery strategies to engineer immunity: A focus on infectious diseases.
    Korkmaz E; Balmert SC; Carey CD; Erdos G; Falo LD
    Expert Opin Drug Deliv; 2021 Feb; 18(2):151-167. PubMed ID: 32924651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent insights into cutaneous immunization: How to vaccinate via the skin.
    Engelke L; Winter G; Hook S; Engert J
    Vaccine; 2015 Sep; 33(37):4663-74. PubMed ID: 26006087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances Towards Painless Vaccination and Newer Modes of Vaccine Delivery.
    Garg N; Aggarwal A
    Indian J Pediatr; 2018 Feb; 85(2):132-138. PubMed ID: 28620730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradermal delivery of mRNA using cryomicroneedles.
    Yu J; Kuwentrai C; Gong HR; Li R; Zhang BZ; Lin X; Wang X; Huang JD; Xu C
    Acta Biomater; 2022 Aug; 148():133-141. PubMed ID: 35697200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging advances in delivery systems for mRNA cancer vaccines.
    Jiang Z; Xu Y; Du G; Sun X
    J Control Release; 2024 Jun; 370():287-301. PubMed ID: 38679162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microneedle Patches as Drug and Vaccine Delivery Platform.
    Li J; Zeng M; Shan H; Tong C
    Curr Med Chem; 2017; 24(22):2413-2422. PubMed ID: 28552053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive delivery technologies: respiratory delivery of vaccines.
    Sullivan VJ; Mikszta JA; Laurent P; Huang J; Ford B
    Expert Opin Drug Deliv; 2006 Jan; 3(1):87-95. PubMed ID: 16370942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocompatible Mater Constructed Microneedle Arrays as a Novel Vaccine Adjuvant- Delivery System for Cutaneous and Mucosal Vaccination.
    Wang T; Wang N
    Curr Pharm Des; 2015; 21(36):5245-55. PubMed ID: 26412356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnologies in Delivery of DNA and mRNA Vaccines to the Nasal and Pulmonary Mucosa.
    Tang J; Cai L; Xu C; Sun S; Liu Y; Rosenecker J; Guan S
    Nanomaterials (Basel); 2022 Jan; 12(2):. PubMed ID: 35055244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunities and Challenges for mRNA Delivery Nanoplatforms.
    Zhang Y; Hu Y; Tian H; Chen X
    J Phys Chem Lett; 2022 Feb; 13(5):1314-1322. PubMed ID: 35107010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines.
    Wei J; Hui AM
    Cancer Treat Rev; 2022 Jun; 107():102405. PubMed ID: 35576777
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 34.